Related Experiment Video
Updated: Mar 24, 2026
07:25
High-throughput Screening of Chemical Compounds to Elucidate Their Effects on Bacterial Persistence
Published on: February 23, 2021
4.6K
Entrepreneurial patent management in pharmaceutical startups
Marcus Holgersson1, Tai Phan2, Thomas Hedner2
1Department of Technology Management and Economics, Chalmers University of Technology, 412 96 Gothenburg, Sweden.
Drug Discovery Today
|March 8, 2016
Summary
Pharmaceutical startups need strategic patent management to navigate challenges like funding and exits. An entrepreneurial approach is crucial for innovation and success in the pharmaceutical industry.
Area of Science:
- Pharmaceutical industry
- Biotechnology
- Innovation management
Background:
- Startups are key drivers of innovation in the pharmaceutical sector.
- Patenting is a critical component for the success of pharmaceutical startups.
- Effective patent management is essential for navigating the complexities of the industry.
Purpose of the Study:
- To explore patent management strategies specifically for pharmaceutical startups.
- To identify key challenges faced by these startups in managing their intellectual property.
- To propose an 'entrepreneurial' approach to patent management.
Main Methods:
- Qualitative analysis of patenting challenges in pharmaceutical ventures.
- Review of factors influencing patent management in startup environments.
- Case study insights into successful pharmaceutical ventures.
Main Results:
- Pharmaceutical startups encounter unique challenges in patenting.
- Resource limitations and funding (venture capital) significantly impact patent strategies.
- Exit strategies and market conditions are critical considerations for patent management.
Conclusions:
- An 'entrepreneurial' patent management approach is necessary for pharmaceutical startups.
- Integrating resource constraints, funding, and exit planning into patent strategy is vital.
- Improved patent management can enhance the success of pharmaceutical ventures and benefit the industry.
Related Concept Videos
01:26Drug Discovery: Overview
12.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
12.9K
01:28Preclinical Development: Overview
6.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
6.4K
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
64
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
64
01:29Pharmacogenomics: Identification of New Drug Targets
76
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
76
01:30Production of Pharmaceuticals
26
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under...
26
01:17Drug Nomenclature
3.6K
During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that...
3.6K